Article

Identification of novel antiviral drug combinations in vitro and tracking their development

2020-09-17

Abstract excerpt

Combination therapies have become a standard for the treatment for HIV and HCV infections. They are advantageous over monotherapies due to better efficacy and reduced toxicity, as well as the ability to prevent the development of resistant viral strains and to treat viral co-infections. Here, we identify several new synergistic combinations against emerging and re-emerging viral infections in vitro . We observed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f9aada89-0d89-5d0f-9c70-1bd8ac4fdf9a
DOI: 10.1101/2020.09.17.299933

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of novel antiviral drug combinations in vitro and tracking their developmentDOI 10.1101/2020.09.17.299933Read

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity Read

The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy RegimensSemantic proximity Read

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesSemantic proximity Read

Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus InfectionsSemantic proximity Read

Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.Semantic proximity Read

Assessment of combined antiviral drug treatment against selected α-, β-, and γ-herpesvirusesSemantic proximity Read

An Overview on Drug Evolution and Trials on Pandemic COVID-19 InfectionSemantic proximity Read

Nucleotide and nucleoside-based drugs: past, present, and futureSemantic proximity Read

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSemantic proximity Read

Treatment of hepatitis C with new fixed dose combinations.Semantic proximity Read

Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell cultureSemantic proximity Read

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antiviralsSemantic proximity Read